Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients

被引:50
|
作者
Huang, Chien-Fang
Li, Tsai-Chung
Lin, Cheng-Chieh
Liu, Chlu-Shong
Shih, Hung-Chang
Lai, Ming-May
机构
[1] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan
[2] China Med Univ Hosp, Clin Lab, Taichung, Taiwan
[3] China Med Univ, Dept Inst Chinese Med & Publ Hlth, Taichung, Taiwan
关键词
hyperlipidemia; lipid ratio; red yeast rice;
D O I
10.1097/HJR.0b013e32801da137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Several lipid ratios may be predictors of coronary artery disease risk. We assessed the efficacy of Monascus purpureus Went rice (red yeast rice) on lowering lipid ratios. Method and results We evaluated 79 hypercholesterolemic patients (aged 23-65 years) who received a twice-daily dose of either red yeast rice or a placebo at 600 mg for 8 weeks. The 8-week treatment with red yeast rice showed significantly greater reduction than the placebo treatment in low-density lipoprotein cholesterol levels, total cholesterol/high-clensity lipoprotein cholesterol, low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and apolipoprotein 13/apolipoprotein A-1 ratios. Conclusions Red yeast rice can reduce lipid ratios in hypercholesterolemic patients.
引用
收藏
页码:438 / 440
页数:3
相关论文
共 50 条
  • [21] Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with type 2 diabetes
    Mori, Yutaka
    Tajima, Naoko
    DIABETES, 2008, 57 : A652 - A652
  • [22] Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus
    Okada, Kenta
    Yagyu, Hiroaki
    Kotani, Kazuhiko
    Miyamoto, Michiaki
    Osuga, Jun-ichi
    Nagasaka, Shoichiro
    Ishibashi, Shun
    ENDOCRINE JOURNAL, 2010, 57 (10) : 903 - 908
  • [23] Comprehensive chemical profiling of monascus-fermented rice product and screening of lipid-lowering compounds other than monacolins
    Liang, Jin-Xiu
    Zhang, Qun-Qun
    Huang, Yan-Fei
    Pang, Han-Qing
    Liu, Xin-Guang
    Gao, Wen
    Li, Ping
    Yang, Hua
    JOURNAL OF ETHNOPHARMACOLOGY, 2019, 238
  • [24] Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes
    Yutaka Mori
    Genshin Kuriyama
    Takaaki Tanaka
    Naoko Tajima
    Endocrine, 2009, 36 : 412 - 418
  • [25] Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes
    Mori, Yutaka
    Kuriyama, Genshin
    Tanaka, Takaaki
    Tajima, Naoko
    ENDOCRINE, 2009, 36 (03) : 412 - 418
  • [26] Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials
    Zhao, Xiang
    Ma, Xubiao
    Luo, Xing
    Shi, Zhihua
    Deng, Ziwen
    Jin, Yuanxiang
    Xiao, Zhipeng
    Tan, Liming
    Liu, Pingfang
    Jiang, Shilong
    Shu, Yuanglu
    Tang, Bing
    Qiu, Chengfeng
    BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01):
  • [27] Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials
    Xiang Zhao
    Xubiao Ma
    Xing Luo
    Zhihua Shi
    Ziwen Deng
    Yuanxiang Jin
    Zhipeng Xiao
    Liming Tan
    Pingfang Liu
    Shilong Jiang
    Yuanglu Shu
    Bing Tang
    Chengfeng Qiu
    BMC Pharmacology and Toxicology, 21
  • [28] Effect of XbaI polymorphism of apolipoprotein B gene on response to lipid lowering therapy in type II hypercholesterolemic patients
    Ye, P
    Shang, YZ
    Wang, SW
    Liu, XY
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 75 - 75
  • [29] Efficacy of lipid-lowering medications in patients treated with clozapine -: A naturalistic study
    Landry, Pierre
    Dimitri, Eric
    Tessier, Sylvie
    Legare, Nancy
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (03) : 348 - 349
  • [30] LIPID LOWERING EFFICACY OF ROSUVASTATIN VS ATORVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE
    Ostergren, J.
    Malmstrom, R.
    Jorgensen, L.
    Walldius, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 205 - 205